Abstract
As in older adults, cardiovascular disease is the most important cause of death in adolescents and young adult patients with end-stage renal disease (ESRD) since childhood. This concerns patients on dialysis as well as transplant patients, despite the fact that a long duration of dialysis during childhood is an extra mortality risk factor. Left ventricular hypertrophy (LVH), aortic valve calcification, and increased arterial stiffness, but not increased arterial intima media thickening, are the most frequently observed alterations in young adult survivors with childhood ESRD. In transplanted patients a concentric LVH as a result of chronic hypertension is mostly observed; in dialysis patients a more asymmetric septal LVH is found as a result of chronic volume overload. These results suggest that in children and young adults with ESRD chronic pressure and volume overload, a high calcium-phosphate product, and chronic inflammation, but not dyslipidemia, play a role in the development of cardiovascular disease.
Similar content being viewed by others
References
Foley RN, Parfrey PS (1998) Cardiovascular disease and mortality in ESRD. J Nephrol 11:239–245
London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767
Huting J (1993) Predictive value of mitral and aortic valve sclerosis for survival in end-stage renal disease on continuous ambulatory peritoneal dialysis. Nephron 64:63–68
Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570–574
Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HAS (2002) Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621–629
Gruppen MP, Groothoff JW, Prins M, Wouw P van der, Offringa M, Bos WJ, Davin JC, Heymans HAS (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 63:1058–1065
Groothoff JW, Gruppen MP, Offringa M, Groot E de, Stok W, Bos WJ, Davin JC, Lilien MR, Van de Kar NC, Wolff ED, Heymans HAS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953–2961
Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105
London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B (1993) Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int [Suppl 41]:S42–S49
Hotta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C (2001) Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 16:324–331
Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003). Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864–868
Mitsnefes MM, Schwartz SM, Daniels SR, Kiball TR, Khoury P, Dtrife CF (2001) Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5:279–284
London GM, Pannier B, Marchais SJ, Guerin AP (2000) Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 11:778–783
Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401
Shurmur SW, D’Elia JA, Gleason RE, Nesto RW, DeSilva RA, Weinrauch LA (1990) Cardiac conduction defects associated with aortic and mitral valve calcification in dialysis patients. Ren Fail 12:103–107
Fernandez-Reyes MJ, Auxiliadora Bajo M, Robles P, Selgas R, Oliver J, Del Peso G, Garcia G, Jimenez C, Garcia-Gallego F (1995) Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factors. Nephrol Dial Transplant 10:2090–2095
Issad B, Mouquet C, Bitker MO, Allouache M, Baumelou A, Rottembourg J, Jacobs C (1994) Is overhydration in CAPD patients a contraindication to renal transplantation? Adv Perit Dial 10:68–72
Merkus MP, Jager KJ, Dekker FW, Haan RJ de, Boeschoten EW, Krediet RT (1999) Cardiovascular and non-cardiovascular survival. The NECOSAD Study Group, in Patients Outcomes in Dialysis Care. Thesis University of Amsterdam
Anwar N, Hutchinson AJ, Gokal R (1993) Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Int 13 [Suppl]:S451–S453
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483
Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833
Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G (1979) Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64:1118–1129
Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789–20796
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987–992
Barenbrock M, Kosch M, Joster E (2002): Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 20:79–84
Girerd X, Laurent S, Pannier B, Asmar R, Safar M (1991) Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J 122:1210–1214
Senzaki H, Akagi M, Hishi T, Ishizawa A, Yanagisawa M, Masutani S, Kobayashi T, Awa S (2002) Age associated changes in arterial elastic properties in children. Eur J Pediatr 161:547–551
Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Gronemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892–1894
Lilien MR, Stroes ES, Op’t Roodt J, Jongh S de, Schroder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684–691
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was presented in part at the IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth, 1–3 April 2004, Heidelberg, Germany
Rights and permissions
About this article
Cite this article
Groothoff, J.W., Lilien, M.R., van de Kar, N.C.A.J. et al. Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol 20, 374–379 (2005). https://doi.org/10.1007/s00467-004-1624-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1624-8